NEWRegulation

Apogee Therapeutics Inc DEF 14A Filing for April 10 Details

Published on 4/10/2026

#APGI#DEF14A#filing
Apogee Therapeutics Inc DEF 14A Filing for April 10 Details

AI Summary

Apogee Therapeutics Inc (APGI) filed its DEF 14A on April 10, 2023. This filing is part of the company's regulatory requirements, detailing executive compensation, corporate governance, and other shareholder information. This event is significant as it provides insights into the company's operational strategies and governance practices. Shareholders often rely on such filings to make informed decisions regarding their investments in APGI.

Source: Read original article (opens in new tab)

Related News

Kalshi secures temporary halt after CFTC intervention
Regulation

Kalshi secures temporary halt after CFTC intervention

Apr 11

IBM (IBM) Settles DEI Allegations for $17 Million
Regulation

IBM (IBM) Settles DEI Allegations for $17 Million

Apr 11

Establishment Labs (ESTA) DEF 14A Filing Reported for April 10
Regulation

Establishment Labs (ESTA) DEF 14A Filing Reported for April 10

Apr 10

AG Mortgage Investment Trust Inc Files DEF 14A for April 10
Regulation

AG Mortgage Investment Trust Inc Files DEF 14A for April 10

Apr 10